Compound Radar

West Pharmaceutical Services, Inc. (WST) Stock Analysis

Price $337.75
Market cap $23.77B
Next earnings Oct 22, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

70
70/100 High Quality
  • Financial Health 85
  • Profitability 60
  • Business Quality 60
  • Balance Sheet 65
  • Cash Flow 80

Why this rating?

Health 70/100 — High Quality

Strongest Financial Health 85/100
Softest Business Quality 60/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

West Pharmaceutical Services, Inc. (WST) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates West Pharmaceutical Services, Inc. 70/100 (High Quality) due to solid business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Fair

Financial highlights

Valuation

  • P/E 43.19
  • Forward P/E 33.89
  • PEG 2.65
  • EV/Revenue 7.16

Profitability

  • Revenue Growth 13.8%
  • Gross Margin 36.8%
  • Operating Margin 22.5%
  • Net Margin 17.0%
  • ROE 19.1%

Financial strength

  • Cash $435.80M
  • Debt $316.50M
  • Net Cash $119.30M
  • Free Cash Flow $468.90M
  • Current Ratio 2.82

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks West Pharmaceutical Services, Inc. (WST).

View Methodology & FAQ →